GeoVax Labs Inc - Company Profile

Powered by

All the data and insights you need on GeoVax Labs Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date GeoVax Labs Inc Strategy Report

  • Understand GeoVax Labs Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

GeoVax Labs Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on GeoVax Labs Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into GeoVax Labs Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

David A. Dodd

President; Chairman; Chief Executive Officer Executive Board Since: 2018 Age: 73

Mr. David A. Dodd has been the Chairman, the Chief Executive Officer (CEO) and President of the company since September 2018. Previously, he served as the Chief Executive Officer and a Director of Medizone International Inc from 2017 to 2018; the President, the Chief Executive Officer and Director of Serologicals Corporation. Prior to this, Mr. Dodd served as the President and the Chief Executive Officer and as a member of the Board at Aeterna Zentaris Inc. Previously, he served as the Chief Executive Officer at RiversEdge BioVentures in 2009, BioReliance Corporation. He also served as the President and Chief Executive Officer of Solvay Pharmaceuticals Inc and as Chairman of its subsidiary Unimed Pharmaceuticals Inc. Mr. Dodd has held various senior management positions at the Mead Johnson Laboratories Division at Bristol-Myers Squibb, Wyeth-Ayerst Laboratories, and Abbott Laboratories.

Read Hide full bio of David A. Dodd

Mark W. Reynolds, CPA

Chief Financial Officer; Corporate Secretary Senior Management Since: 2006 Age: 61

Mr. Mark W. Reynolds has been the Chief Financial Officer and Corporate Secretary of GeoVax since October 2006. Prior to this, he served as the Chief Financial Officer at HealthWatchSystems, Inc. from 2004 to 2008; as the Chief Financial Officer at Duska Therapeutics Inc, from 2004 to 2006, and as the Chief Financial Officer at CytRx Corporation from 1988 to 2002. Mr. Reynolds also worked as an Auditor for Arthur Andersen & Co from 1985 to 1988.

Read Hide full bio of Mark W. Reynolds, CPA

Kelly T. McKee, M.D.

Chief Medical Officer Senior Management Since: 2022 Age: 73

Mr. Kelly McKee has been Chief Medical Officer of the company since January 2022.

Read Hide full bio of Kelly T. McKee, M.D.

Mark J. Newman, Ph.D.

Chief Scientific Officer Senior Management Since: 2020 Age: 68

Dr. Mark J. Newman has been the Chief Scientific Officer of the company since 2020. Prior to this role, he served as vice president of research and development from 2010 to 2013 in the company. Prior to this role, he served senior management positions at PaxVax, Pharmexa A/S, Epimmune, Vaxcel, Apollon, and Cambridge Biotech.

Read Hide full bio of Mark J. Newman, Ph.D.

Harriet L. Robinson, Ph.D.

Chief Scientific Officer - Emeritus, GeoVax Senior Management Since: 2007
Gain a 360-degree view of GeoVax Labs Inc and make more informed decisions for your business Gain a 360-degree view of GeoVax Labs Inc and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer